Header Logo

Connection

Moosa Patel to Cyclophosphamide

Back to Details
This is a "connection" page, showing publications Moosa Patel has written about Cyclophosphamide.
Moosa Patel
Connection Strength
0,042
Cyclophosphamide
  1. Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study. Leuk Lymphoma. 2019 12; 60(14):3375-3385.
    View in: PubMed
    Score: 0,042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.